Process development of (2-nitrophenylcarbamoyl)-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-n-benzyl-n- methylamide (SDZ NKT343)

Organic Process Research and Development

Volumn 3, Issue 6, 1999, Pages 409-415

  Prashad, Mahavir ^a   Prasad, Kapa ^a   Repic, Oljan ^a   Blacklock, Thomas J ^a   Prikoszovich, Walter ^b  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033477044     PISSN: 10836160     EISSN: None     Source Type: Journal    
DOI: 10.1021/op990188a     Document Type: Article

References (2)

1. Walpole, C; Ko, S. Y.; Brown, M.; Beattie, D.; Campbell, E.; Dickenson, F.; Swan, S.; Hughes, G. A.; Lemaire, M.; Lerpiniere, J.; Patel, S.; Urban, L. J. Med. Chem. 1998, 41, 3159-3173.
2. Ko, S. Y.; Walpole, C. WO 96/18643, June 20, 1996.